Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.32 |
| ▸ | XRCC6 | P12956 | 1/20 | 0.32 |
| ▸ | XRCC5 | P13010 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 3/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21940070 | 0.92 | PLA2G2A (0.36) | ESR1ESR2ALDH1A1CYP1A2CA1 | |
| SCHEMBL26019202 | 0.90 | PLA2G2A (0.35) | ESR1ESR2ALDH1A1CYP1A2CA1 | |
| SCHEMBL23109602 | 0.90 | PLA2G2A (0.35) | ESR1ESR2ALDH1A1CYP1A2CA1 | |
| SCHEMBL23814346 | 0.90 | XRCC6 (0.31) | XRCC6XRCC5PRKDCAHR | |
| SCHEMBL26010882 | 0.88 | PLA2G2A (0.38) | ESR1ESR2ALDH1A1CYP1A2KDM4E | |
| SCHEMBL25684384 | 0.88 | PLA2G2A (0.38) | ESR1ESR2ALDH1A1CYP1A2KDM4E | |
| SCHEMBL25688105 | 0.87 | ENPP3 (0.34) | ALDH1A1CYP1A2CYP2C9CYP2C19CA1 | |
| SCHEMBL24908330 | 0.87 | PLA2G2A (0.37) | ESR1ESR2ALDH1A1CYP1A2KDM4E | |
| SCHEMBL23109323 | 0.85 | PLA2G2A (0.34) | ESR1ESR2ALDH1A1CYP1A2KDM4E | |
| SCHEMBL24908172 | 0.85 | PGR (0.38) | ESR1ESR2ALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019712-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-10777752-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-09-15 | — | — | US | disclosed |
| US-10763441-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-20200111973-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200111973-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, MRPS22 | ESR1 6/4885ESR2 7/4885ALDH1A1 459/4885 |
| US-10777752-B2 | Organic electroluminescence device and electronic apparatus provided with the same | RER1, RPS19, MRPS22 | ESR1 6/4885ESR2 7/4885ALDH1A1 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.